Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy.
Linders D, Deken M, van der Valk M, Tummers W, Bhairosingh S, Schaap D, van Lijnschoten G, Zonoobi E, Kuppen P, van de Velde C, Vahrmeijer A, Farina Sarasqueta A, Sier C, Hilling D. Linders D, et al. Among authors: schaap d. Diagnostics (Basel). 2021 Mar 14;11(3):516. doi: 10.3390/diagnostics11030516. Diagnostics (Basel). 2021. PMID: 33799475 Free PMC article.
Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer.
de Valk KS, Deken MM, Schaap DP, Meijer RP, Boogerd LS, Hoogstins CE, van der Valk MJ, Kamerling IM, Bhairosingh SS, Framery B, Hilling DE, Peeters KC, Holman FA, Kusters M, Rutten HJ, Cailler F, Burggraaf J, Vahrmeijer AL. de Valk KS, et al. Among authors: schaap dp. Ann Surg Oncol. 2021 Mar;28(3):1832-1844. doi: 10.1245/s10434-020-09069-2. Epub 2020 Oct 9. Ann Surg Oncol. 2021. PMID: 33034788 Free PMC article. Clinical Trial.
Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL. Boogerd LSF, et al. Among authors: schaap dp. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30. Lancet Gastroenterol Hepatol. 2018. PMID: 29361435
Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT. Voogt ELK, et al. Among authors: schaap dp. Eur J Surg Oncol. 2021 Sep;47(9):2429-2435. doi: 10.1016/j.ejso.2021.05.017. Epub 2021 May 18. Eur J Surg Oncol. 2021. PMID: 34030921
Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT. Voogt ELK, et al. Among authors: schaap dp. Eur J Surg Oncol. 2021 Sep;47(9):2473-2474. doi: 10.1016/j.ejso.2021.06.021. Epub 2021 Jun 24. Eur J Surg Oncol. 2021. PMID: 34210580 No abstract available.
Prognostic Implications of MRI-Detected EMVI and Tumor Deposits and Their Response to Neoadjuvant Therapy in cT3 and cT4 Rectal Cancer.
Schaap DP, Voogt ELK, Burger JWA, Cnossen JS, Creemers GM, van Lijnschoten I, Nieuwenhuijzen GAP, Rutten HJT, Daniels-Gooszen AW, Nederend J, Kusters M. Schaap DP, et al. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):816-825. doi: 10.1016/j.ijrobp.2021.06.013. Epub 2021 Jun 17. Int J Radiat Oncol Biol Phys. 2021. PMID: 34146635 Free article.
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).
van den Berg K, Schaap DP, Voogt ELK, Buffart TE, Verheul HMW, de Groot JWB, Verhoef C, Melenhorst J, Roodhart JML, de Wilt JHW, van Westreenen HL, Aalbers AGJ, van 't Veer M, Marijnen CAM, Vincent J, Simkens LHJ, Peters NAJB, Berbée M, Werter IM, Snaebjornsson P, Peulen HMU, van Lijnschoten IG, Roef MJ, Nieuwenhuijzen GAP, Bloemen JG, Willems JMWE, Creemers GJM, Nederend J, Rutten HJT, Burger JWA. van den Berg K, et al. Among authors: schaap dp. BMC Cancer. 2022 Sep 6;22(1):957. doi: 10.1186/s12885-022-09947-w. BMC Cancer. 2022. PMID: 36068495 Free PMC article.
Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, Beets GL, Suzuki C, Toda S, Lee IK, Sammour T, Uehara K, Lee P, Tuynman JB, van de Velde CJH, Rutten HJT, Kusters M; Lateral Node Study Consortium. Schaap DP, et al. Br J Surg. 2021 Mar 12;108(2):205-213. doi: 10.1093/bjs/znaa009. Br J Surg. 2021. PMID: 33711144
53 results